Author | Zhu Shen


Pharmaceutical Executive

Unleash the Dragon

China's large patient base and concentrated specialty hospitals make it easier to recruit patients for clinical trials in than in the United States. On average, companies can save from two to five months by conducting a Phase I study in China.